(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 14.66%
-0.78% $ 10.15
@ $14.75
Wydano: 14 vas. 2024 @ 20:48
Zwrot: -31.19%
Poprzedni sygnał: vas. 14 - 18:25
Poprzedni sygnał:
Zwrot: 0.20 %
Live Chart Being Loaded With Signals
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes...
Stats | |
---|---|
Dzisiejszy wolumen | 428 146 |
Średni wolumen | 434 516 |
Kapitalizacja rynkowa | 584.43M |
EPS | $0.590 ( 2024-02-09 ) |
Następna data zysków | ( $0.430 ) 2024-05-09 |
Last Dividend | $0.150 ( 2023-12-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 10.57 |
ATR14 | $0.0120 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-04-01 | Reidy Christopher R | Sell | 0 | Common Stock |
2022-04-01 | Melcher David F | Sell | 0 | Common Stock |
2024-04-04 | Kurdikar Devdatt | Sell | 4 535 | Common Stock |
2024-02-11 | Kurdikar Devdatt | Sell | 17 165 | Common Stock |
2024-02-12 | Melcher David F | Buy | 2 000 | Common Stock |
INSIDER POWER |
---|
77.57 |
Last 100 transactions |
Buy: 2 135 787 | Sell: 79 609 |
Wolumen Korelacja
Embecta Corp. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
APPS | 0.966 |
CMLS | 0.966 |
LBRDA | 0.965 |
LBRDK | 0.963 |
BMRC | 0.961 |
PETS | 0.961 |
GPRO | 0.959 |
SPTN | 0.958 |
GP | 0.956 |
CWCO | 0.955 |
10 Najbardziej negatywne korelacje | |
---|---|
SVFA | -0.967 |
RAM | -0.967 |
GXII | -0.966 |
VPCB | -0.966 |
AEAC | -0.965 |
THAC | -0.964 |
SVFB | -0.962 |
FNVT | -0.962 |
TCOM | -0.962 |
AGGR | -0.961 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Embecta Corp. Korelacja - Waluta/Towar
Embecta Corp. Finanse
Annual | 2023 |
Przychody: | $1.12B |
Zysk brutto: | $749.90M (66.91 %) |
EPS: | $1.230 |
FY | 2023 |
Przychody: | $1.12B |
Zysk brutto: | $749.90M (66.91 %) |
EPS: | $1.230 |
FY | 2022 |
Przychody: | $1.13B |
Zysk brutto: | $774.90M (68.61 %) |
EPS: | $3.92 |
FY | 2021 |
Przychody: | $1.17B |
Zysk brutto: | $800.00M (68.67 %) |
EPS: | $7.28 |
Financial Reports:
No articles found.
Embecta Corp. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 2022-08-25 |
Last Dividend | $0.150 | 2023-12-01 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $0.900 | -- |
Avg. Dividend % Per Year | 0.90% | -- |
Score | 2.81 | -- |
Div. Sustainability Score | 4.97 | |
Div.Growth Potential Score | 0.978 | |
Div. Directional Score | 2.98 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.300 | 0.64% |
2023 | $0.600 | 2.37% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0493 | 1.500 | 9.01 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0454 | 1.200 | 8.49 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.0681 | 1.500 | -1.868 | -2.80 | [0.1 - 1] |
payoutRatioTTM | 0.778 | -1.000 | 2.22 | -2.22 | [0 - 1] |
currentRatioTTM | 2.20 | 0.800 | 3.99 | 3.19 | [1 - 3] |
quickRatioTTM | 1.547 | 0.800 | 5.61 | 4.49 | [0.8 - 2.5] |
cashRatioTTM | 0.915 | 1.500 | 6.03 | 9.05 | [0.2 - 2] |
debtRatioTTM | 1.344 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 1.633 | 1.000 | -0.506 | -0.506 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.101 | 2.00 | -0.0336 | -0.0673 | [0 - 30] |
freeCashFlowPerShareTTM | -0.527 | 2.00 | -0.264 | -0.527 | [0 - 20] |
debtEquityRatioTTM | -2.06 | -1.500 | -8.25 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.666 | 1.000 | 2.24 | 2.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.159 | 1.000 | 8.82 | 8.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00354 | 1.000 | -1.131 | -1.131 | [0.2 - 2] |
assetTurnoverTTM | 0.922 | 0.800 | 7.19 | 5.75 | [0.5 - 2] |
Total Score | 4.97 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.55 | 1.000 | 9.04 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0681 | 2.50 | -1.201 | -2.80 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.527 | 2.00 | -0.176 | -0.527 | [0 - 30] |
dividendYielPercentageTTM | 5.91 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.101 | 2.00 | -0.0336 | -0.0673 | [0 - 30] |
payoutRatioTTM | 0.778 | 1.500 | 2.22 | -2.22 | [0 - 1] |
pegRatioTTM | -0.154 | 1.500 | -4.36 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00517 | 1.000 | -2.63 | 0 | [0.1 - 0.5] |
Total Score | 0.978 |
Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej